Extracorporeal carbon dioxide removal (ECCO2R) in COPD and ARDS patients with severe hypercapnic respiratory failure. A retrospective case-control study

Published in: Turkish journal of medical sciences (2021)

ECCO2R therapy significantly improved survival, iMV duration and LOS in patients with severe HRF due to COPD or ARDS, and successfully provided LPV approaches. Further studies are needed to assess promising benefits of ECCO2R therapy.

Keyphrases

respiratory failure
extracorporeal membrane oxygenation
mechanical ventilation
carbon dioxide
acute respiratory distress syndrome
chronic obstructive pulmonary disease
early onset
lung function
intensive care unit
stem cells
bone marrow
air pollution
cell therapy
case control